Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose
2 other identifiers
interventional
100
1 country
2
Brief Summary
This Type 1 hybrid effectiveness-implementation randomized controlled trial, Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of fentanyl test strips on overdose outcomes, using a novel 2x2 design crossing fentanyl test strip distribution and education to determine which approach most significantly reduces overdose rates while minimizing costs. This research will inform scalability around mail-based fentanyl test strip distribution and education programs to address the nation's opioid overdose crisis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
September 1, 2027
April 13, 2026
April 1, 2026
1 year
August 13, 2025
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overdose
Includes both self-reported non-fatal overdose and fatal overdose as reported by the National Death Index.
Baseline, 1 month, 3 months, 6 months
Secondary Outcomes (1)
Fentanyl test strip knowledge
Baseline, 1 month, 3 months, 6 months
Other Outcomes (6)
Protective Behavioral Strategies
Baseline, 1 month, 3 months, 6 months
Types of drugs tested with fentanyl test strips
Baseline, 1 month, 3 months, 6 months
Number of fentanyl test strips used
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months
- +3 more other outcomes
Study Arms (4)
FDE
EXPERIMENTALThis arm receives both FTS distribution (FTS delivered to their residential address) and education (FDE), as well as a resource list for naloxone and additional FTS if desired.
E
EXPERIMENTALThe Education only (E) arm receives FTS education as well as a resource list for obtaining naloxone and FTS.
FD
EXPERIMENTALThe FTS distribution only (FDE) arm receives FTS delivered to their residential address as well as a resource list for obtaining naloxone and additional FTS, if desired.
R
NO INTERVENTIONThe referral only (R) arm receives a resource list for obtaining naloxone and FTS.
Interventions
Fentanyl test strips (FTS) are small strips of paper that can detect the presence of fentanyl in illicit drugs.
Developed in the R61 phase, the educational intervention will provide participants with knowledge about how to correctly use fentanyl strips.
Eligibility Criteria
You may qualify if:
- years old
- English-speaking and reading
- Report using illicit opioids and/or stimulants (including counterfeit pills) within the past 3 months per the ASSIST
- Able and willing to provide informed consent
- Reside in any of the US states where fentanyl test strips are legal with no plans to move out of state for at least 12 months
- Reside in any of the US states where FTS are legal with no plans to move out of state for at least 12 months
- Be able and willing to provide the names and contact information of three close contacts to reach if the participant cannot be reached
You may not qualify if:
- Living in a restricted environment (e.g., prison)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 13, 2025
First Posted
August 19, 2025
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share